• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Promising liver transplant outcomes at 20 years

bys25qthea
August 11, 2013
in Chronic Disease, Gastroenterology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Liver transplant recipients have good long-term outcomes, with 52.5% of patients alive after 20 years. 

2. Most deaths are attributable to complications of long-term immunosuppression such as infection, malignancy, and cardiovascular disease. 

Evidence Rating Level: 2 (Good) 

Study Rundown: While short-term survival for liver transplantation (LT) has improved dramatically due to increasing technical expertise and enhanced immunosuppression, long-term results have been slower to follow. This single-center longitudinal study evaluated factors affecting 20-year LT outcomes, finding highly promising results with 52.5% of patients alive after 20 years and elderly LT recipients surviving at similar rates to the normal population. Many deaths were likely due to prolonged immunosuppression, calling for its continued optimization. Additionally, the high incidence of cardiovascular disease and lung cancer in particular suggest that more care must be taken in reducing risk factors in this population. Organ allocation policy and immune suppression have changed dramatically over the past 20 years, making generalization of these results to the current group of transplant patients difficult..

Click to read the study in Am J Transplantation

Relevant Reading: Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

RELATED REPORTS

Postoperative supplemental oxygen in liver transplantation not associated with reduced infection risk

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

In-Depth [retrospective cohort study]: 313 consecutive patients from a single center were prospectively observed over 20 years for overweight, hypertension, diabetes, hyperlipidemia, and moderately or severely impaired renal function. Excluding patients who died within 6 months after transplant, patient survival at 1, 10, and 20 years was 97.6%, 80.8%, and 58.8%. Gender, age, retransplantation, etiology, and impaired renal function at 6 months were found to significantly impact survival. Patients with biliary malignancies and HCC showed significantly worse survival rates (24.7% at 20 years), while those with autoimmune or cholestatic disease had better survival (67.5%). Interestingly, prolonged cold ischemia time did not significantly impact patient or graft survival. The most common causes of death were recurrent disease (21.3%), infection (20.6%), de novo malignancy (19.9%), and cardiovascular disease (14.9%).  Lung cancer in particular accounted for 42.9% of lethal de novo malignancies.

By Mariya Samoylova and Chaz Carrier

More from this author: Endovascular repair of ruptured AAAs no better than open repair Transfusion worsens outcomes for HCV+ liver transplant recipients 

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: immunosuppressionliver transplanttransplant
Previous Post

Flu vaccine not associated with adverse pregnancy outcomes

Next Post

Viagra provides pain relief in primary dysmenorrhea

RelatedReports

Adaptive ventilation for central sleep apnea linked to increased mortality in heart failure patients
Gastroenterology

Postoperative supplemental oxygen in liver transplantation not associated with reduced infection risk

February 27, 2023
Resection of colorectal liver metastases may improve cost and longevity
Chronic Disease

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

January 30, 2023
Study explores effects of daily iron supplementation in 2- to 5-year-olds
Oncology

Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

November 7, 2022
Wellness

Wellness Check: Spirituality

October 27, 2022
Next Post
C-section surgical techniques yield equivalent outcomes

Viagra provides pain relief in primary dysmenorrhea

2 Minute Medicine Rewind: May 13 – May 19

2 Minute Medicine Rewind August 4- August 11, 2013

X-ray after foreign body removal by esophagoscopy is not cost effective

Inhaled nitric oxide in premature infants shows no benefits

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options